Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B

Published:2017-05-30 Issue:6 Volume:32 Page:1250-1257
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Li Jia¹,Gordon Stuart C²,Rupp Loralee B³,Zhang Talan¹,Trudeau Sheri¹,Holmberg Scott D⁴,Moorman Anne C⁴,Spradling Philip R⁴,Teshale Eyasu H⁴,Boscarino Joseph A⁵,Daida Yihe G⁶,Schmidt Mark A⁷,Lu Mei¹,

Affiliation:

1. Department of Public Health SciencesHenry Ford Health System Detroit Michigan USA

2. Division of Gastroenterology and HepatologyHenry Ford Health System Detroit Michigan USA

3. Center for Health Policy and Health Services ResearchHenry Ford Health System Detroit Michigan USA

4. Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB PreventionCenters for Disease Control and Prevention Atlanta Georgia USA

5. Center for Health ResearchGeisinger Health System Danville Pennsylvania USA

6. Center for Health ResearchKaiser Permanente–Hawai'i Waipahu Hawaii USA

7. Center for Health ResearchKaiser Permanente–Northwest Portland Oregon USA

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.13667

Reference29 articles.

1. AASLD guidelines for treatment of chronic hepatitis B

2. Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?